{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:28:21Z","timestamp":1762928901588},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In a context where SARS-CoV-2 population-wide testing is implemented, clinical features and antibody response in those infected have never been documented in Africa. Yet, the information provided by analyzing data from population-wide testing is critical to understand the infection dynamics and devise control strategies. We described clinical features and assessed antibody response in people screened for SARS-CoV-2 infection. We analyzed data from a cohort of 3464 people that we molecularly screened for SARS-CoV-2 infection in our routine activity. We recorded people SARS-CoV-2 diagnosis, age, gender, blood types, white blood cells (WBC),\u00a0symptoms, chronic disease status and time to SARS-CoV-2 RT-PCR conversion from positive to negative. We calculated the age-based distribution of SARS-CoV-2 infection, analyzed the proportion and the spectrum of COVID-19 severity. Furthermore, in a nested sub-study, we screened 83 COVID-19 patients and 319 contact-cases for anti-SARS-CoV-2 antibodies. Males and females accounted for respectively 51% and 49% of people screened. The studied population median and mean age were both 39\u00a0years. 592 out of 3464 people (17.2%) were diagnosed with SARS-CoV-2 infection with males and females representing, respectively, 53% and 47%. The median and mean ages of SARS-CoV-2 infected subjects were 37 and 38\u00a0years respectively. The lowest rate of infection (8%) was observed in the elderly (aged\u2009&gt;\u200960). The rate of SARS-Cov-2 infection in both young (18\u201335\u00a0years old) and middle-aged adults (36\u201360\u00a0years old) was around 20%. The analysis of SARS-CoV-2 infection age distribution showed that middle-aged adults accounted for 54.7% of SARS-CoV-2 positive persons, followed respectively by young adults (33.7%), children (7.7%) and elderly (3.8%). 68% (N\u2009=\u2009402) of SARS-CoV-2 infected persons were asymptomatic, 26.3% (N\u2009=\u2009156) had influenza-like symptoms, 2.7% (N\u2009=\u200916) had influenza-like symptoms associated with anosmia and ageusia, 2% (N\u2009=\u200911) had dyspnea and 1% (N\u2009=\u20097) had respiratory failure, which resulted in death. Data also showed that 12% of SARS-CoV-2 infected subjects, had chronic diseases. Hypertension, diabetes, and asthma were the top concurrent chronic diseases representing respectively 58%, 25% and 12% of recorded chronic diseases. Half of SARS-CoV-2 RT-PCR positive patients were cured within 14\u00a0days following the initiation of the anti-COVID-19 treatment protocol. 78.3% of COVID-19\u00a0patients and 55% of SARS-CoV-2 RT-PCR confirmed negative contact-cases were positive for anti-SARS-CoV-2 antibodies. Patients with severe-to-critical illness have higher leukocytes, higher neutrophils and lower lymphocyte counts contrarily to asymptomatic patients and patients with mild-to-moderate illness.\u00a0Neutrophilic leukopenia was more prevalent\u00a0in asymptomatic patients and patients with mild-to-moderate disease for 4 weeks after diagnosis (27.1\u201342.1%). In Patients with severe-to-critical illness, neutrophilic leukocytosis or neutrophilia (35.6\u201350%) and lymphocytopenia (20\u201340%) were more frequent.\u00a0More than 60% of participants were blood type O. It is also important to note that infection rate was slightly higher among A and B blood types compared with type O. In this African setting, young and middle-aged adults are most likely driving community transmission of COVID-19. The rate of critical disease is relatively low. The high rate of anti-SARS-CoV-2 antibodies observed in SARS-CoV-2 RT-PCR negative contact cases suggests that subclinical infection may have been overlooked in our setting.<\/jats:p>","DOI":"10.1038\/s41598-021-87043-y","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T10:04:35Z","timestamp":1620295475000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dynamic and features of SARS-CoV-2 infection in Gabon"],"prefix":"10.1038","volume":"11","author":[{"given":"Amandine","family":"Mveang Nzoghe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy-Stephan","family":"Padzys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anicet Christel","family":"Maloupazoa Siawaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisca","family":"Kandet Yattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marielle","family":"Leboueny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotimi Myrabelle","family":"Avome Houechenou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliode Cyrien","family":"Bongho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedrick","family":"Mba-Mezeme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofilia","family":"Mvoundza Ndjindji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Biteghe-Bi-Essone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Boulende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulin N.","family":"Essone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carene Anne Alene","family":"Ndong Sima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulysse","family":"Minkobame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carinne","family":"Zang Eyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Ndeboko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Voloc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Meye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Ategbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Fleury","family":"Djoba Siawaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"87043_CR1","doi-asserted-by":"crossref","unstructured":"Giandhari J, Pillay S, Wilkinson E, et al. Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report. medRxiv 2020: 2020.05.29.20116376.","DOI":"10.1101\/2020.05.29.20116376"},{"key":"87043_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ijerph17093054","volume":"17","author":"OA Adegboye","year":"2020","unstructured":"Adegboye, O. A., Adekunle, A. I. & Gayawan, E. Early transmission dynamics of novel coronavirus (COVID-19) in Nigeria. Int. J. Environ. Res. Public Health 17, 9 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"87043_CR3","unstructured":"Ntoumi, F., Velavan, T.P. COVID-19 in Africa: Between hope and reality. The Lancet Infectious Diseases."},{"issue":"10","key":"87043_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1473-3099(20)30708-8","volume":"20","author":"M Makoni","year":"2020","unstructured":"Makoni, M. COVID-19 in Africa: Half a year later. Lancet. Infect. Dis 20(10), 1127 (2020).","journal-title":"Lancet. Infect. Dis"},{"key":"87043_CR5","doi-asserted-by":"publisher","first-page":"108441","DOI":"10.1016\/j.mbs.2020.108441","volume":"328","author":"SM Garba","year":"2020","unstructured":"Garba, S. M., Lubuma, J. M. S. & Tsanou, B. Modeling the transmission dynamics of the COVID-19 Pandemic in South Africa. Math. Biosci. 328, 108441 (2020).","journal-title":"Math. Biosci."},{"key":"87043_CR6","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1017\/S0950268820001983","volume":"148","author":"E Gayawan","year":"2020","unstructured":"Gayawan, E. et al. The spatio-temporal epidemic dynamics of COVID-19 outbreak in Africa. Epidemiol. Infect. 148, e212 (2020).","journal-title":"Epidemiol. Infect."},{"issue":"10","key":"87043_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","volume":"8","author":"E Barron","year":"2020","unstructured":"Barron, E. et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: A whole-population study. Lancet Diabetes Endocrinol. 8(10), 813\u2013822 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"20","key":"87043_CR8","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1182\/bloodadvances.2020002657","volume":"4","author":"MB Barnkob","year":"2020","unstructured":"Barnkob, M. B. et al. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Adv. 4(20), 4990\u20134993 (2020).","journal-title":"Blood Adv."},{"issue":"20","key":"87043_CR9","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1182\/bloodadvances.2020002623","volume":"4","author":"RL Hoiland","year":"2020","unstructured":"Hoiland, R. L. et al. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 4(20), 4981\u20134989 (2020).","journal-title":"Blood Adv."},{"issue":"5","key":"87043_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11739-020-02379-z","volume":"15","author":"F Lapostolle","year":"2020","unstructured":"Lapostolle, F. et al. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: The COVID-call study. Intern. Emerg. Med 15(5), 813\u2013817 (2020).","journal-title":"Intern. Emerg. Med"},{"key":"87043_CR11","volume-title":"Coronavirus disease 2019 (COVID-19) in the EU\/EEA and the UK\u2013eleventh update: resurgence of cases","author":"ECDC","year":"2020","unstructured":"ECDC. Coronavirus disease 2019 (COVID-19) in the EU\/EEA and the UK\u2013eleventh update: resurgence of cases (European Centre for Disease Prevention and Control, 2020)."},{"key":"87043_CR12","unstructured":"Venkatesan P. The changing demographics of COVID-19. The Lancet Respiratory Medicine."},{"key":"87043_CR13","doi-asserted-by":"crossref","unstructured":"TK B, J D, E C, al. e. Changing Age Distribution of the COVID-19 Pandemic\u2014United States, May\u2013August 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1404\u20139.","DOI":"10.15585\/mmwr.mm6939e1"},{"key":"87043_CR14","doi-asserted-by":"publisher","first-page":"m1165","DOI":"10.1136\/bmj.m1165","volume":"368","author":"M Day","year":"2020","unstructured":"Day, M. Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ 368, m1165 (2020).","journal-title":"BMJ"},{"issue":"6","key":"87043_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jmv.25748","volume":"92","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Wang, Y., Chen, Y. & Qin, Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J. Med. Virol. 92(6), 568\u2013576 (2020).","journal-title":"J. Med. Virol."},{"issue":"5","key":"87043_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11739-020-02379-z","volume":"15","author":"F Lapostolle","year":"2020","unstructured":"Lapostolle, F. et al. Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: The COVID-call study. Intern. Emerg. Med. 15(5), 813\u2013817 (2020).","journal-title":"Intern. Emerg. Med."},{"issue":"8","key":"87043_CR17","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1038\/s41375-020-0910-1","volume":"34","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Hematological features of persons with COVID-19. Leukemia 34(8), 2163\u20132172 (2020).","journal-title":"Leukemia"},{"issue":"9","key":"87043_CR18","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","volume":"7","author":"D Liao","year":"2020","unstructured":"Liao, D. et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: A retrospective cohort study. Lancet Haematol. 7(9), e671\u2013e678 (2020).","journal-title":"Lancet Haematol."},{"issue":"Suppl 1","key":"87043_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ijlh.13229","volume":"42","author":"JL Frater","year":"2020","unstructured":"Frater, J. L., Zini, G., d\u2019Onofrio, G. & Rogers, H. J. COVID-19 and the clinical hematology laboratory. Int. J. Lab. Hematol. 42(Suppl 1), 11\u201318 (2020).","journal-title":"Int. J. Lab. Hematol."},{"issue":"6","key":"87043_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/20009666.2020.1808360","volume":"10","author":"M Asghar","year":"2020","unstructured":"Asghar, M., Hussain, N., Shoaib, H., Kim, M. & Lynch, T. J. Hematological characteristics of patients in coronavirus 19 infection: A systematic review and meta-analysis. J. Commun. Hosp. Internal Med. Perspect. 10(6), 508\u2013513 (2020).","journal-title":"J. Commun. Hosp. Internal Med. Perspect."},{"key":"87043_CR21","doi-asserted-by":"publisher","first-page":"104575","DOI":"10.1016\/j.jcv.2020.104575","volume":"130","author":"S Fill Malfertheiner","year":"2020","unstructured":"Fill Malfertheiner, S. et al. Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study. J. Clin. Virol. 130, 104575 (2020).","journal-title":"J. Clin. Virol."},{"key":"87043_CR22","doi-asserted-by":"crossref","unstructured":"Zhao, J., .Yuan, Q., Wang, H., et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020.","DOI":"10.1101\/2020.03.02.20030189"},{"issue":"8","key":"87043_CR23","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/cid\/ciaa461","volume":"71","author":"F Xiang","year":"2020","unstructured":"Xiang, F. et al. Antibody detection and dynamic characteristics in patients with coronavirus disease 2019. Clin. Infect. Dis. 71(8), 1930\u20131934 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"87043_CR24","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/S2666-5247(20)30053-7","volume":"1","author":"KKW To","year":"2020","unstructured":"To, K. K. W. et al. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: A multicohort study. Lancet Microbe 1(3), e111\u2013e118 (2020).","journal-title":"Lancet Microbe"},{"issue":"12","key":"87043_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.cmi.2019.04.012","volume":"25","author":"KKW To","year":"2019","unstructured":"To, K. K. W. et al. Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: A prospective cohort study. Clin. Microbiol. Infect. 25(12), 1539\u20131545 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"87043_CR26","doi-asserted-by":"crossref","unstructured":"Liu, N., Zhang, T., Ma, L., et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Reviews 2020: 100785.","DOI":"10.1016\/j.blre.2020.100785"},{"issue":"1","key":"87043_CR27","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1038\/s41467-020-19623-x","volume":"11","author":"M Zietz","year":"2020","unstructured":"Zietz, M., Zucker, J. & Tatonetti, N. P. Associations between blood type and COVID-19 infection, intubation, and death. Nat. Commun. 11(1), 5761 (2020).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87043-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87043-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:48:12Z","timestamp":1670053692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87043-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87043"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87043-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9672"}}